インデックス付き
  • 学術雑誌データベース
  • Jゲートを開く
  • Genamics JournalSeek
  • ジャーナル目次
  • 中国国家知識基盤 (CNKI)
  • シマゴ
  • ウルリッヒの定期刊行物ディレクトリ
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ミアル
  • 大学補助金委員会
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • Google スカラー
このページをシェアする

概要

Comparative Analysis of Emerging Viruses to Inform Development of Safe and Effective Vaccines for COVID-19

Sabiha Noor, Shabnam Sambyal, Saif Ismail, Narendra Chirmule*

Viruses have evolved by surviving in hosts over millions of years. The human immune system has also co-evolved to counter the escape mechanisms of viruses. Each virus has a unique and specific mechanism of causing disease. SARS-COV2 has emerged as a newly mutated virus that has resulted in a world-wide pandemic. Understanding immunobiology of viruses provides information on developing diagnostics, therapeutics, and vaccines. We have reviewed and summarized the pathogenesis of four viruses that have emerged as causative agents for endemics in the past decade. Dengue, Chikungunya, Nipah and Zika viruses i) are transmitted by different intermediate animal hosts, ii) infect cells through different receptors, iii) induce a diverse range of symptoms, iv) which are treated with specific and symptomatic therapies, and v) various proteins expressed by the viruses used as antigens for diagnosis and development of vaccines. The nature of the immune response to these viruses involves innate, cell mediated and humoral immunity, and several proteins of these viruses have been implicated in protective versus pathogenic responses. We have summarized and provided recent references for the current understanding of SARS-COV2 virus and immunological immune responses, and listed similarities and difference in characteristics to these four viruses. This systematic analysis of these viruses will enable the understanding the requirements and anticipate challenges in development of novel diagnostics, therapies, and vaccines for COVID-19 pandemic.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません